Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

2016 In Review: FDA Transparency, Claims Enforcement A One-Off?

Jan 03 2017

• By Ryan Nelson

2016

Related Content

FDA Warnings Slow, But Anti-Aging Claims Remain Class Action Targets

Dec 28 2016

Not Just J&J’s Problem: The Evolving Talc Litigation Landscape

Dec 13 2016

Cosmetics Adverse Events Under Spotlight In FDA Transparency Push

Dec 07 2016

FDA Cosmetics Director: ‘Sporadic’ WEN AERs Make Case For Mandatory Reporting

Dec 09 2016

Freedom Caucus Hit List Includes Antibacterial Soap, Supplement Label Rules

Dec 20 2016

Jan Marini Focused On Damage Control Following FDA Seizure Of Eyelash Item

Nov 26 2007

FDA’s Candid Overview Of Cosmetics Regime Signals Support For Reform Bill

Oct 14 2016

<em>WEN</em> Will Guthy-Renker, Chaz Dean Put Hair-Loss Ordeal Behind Them?

Nov 28 2016

FDA Divulges Cosmetics Enforcement Data, Notes Hair Loss As ‘Serious’ AE

Nov 03 2016

Related Companies

Johnson & Johnson

Additional Topics

United States Regulation Compliance Safety Cosmetics Consumer

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window